These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 5224007)
61. Riboflavin metabolism in liver diseases. IV. Enzymatic splitting and synthesis of flavin adenine dinucleotide in the p-dimethylaminoazobenzene induced rat liver carcinoma tissue. Yang WK; Sung JL Taiwan Yi Xue Hui Za Zhi; 1966 Jun; 65(6):299-305. PubMed ID: 5224006 [No Abstract] [Full Text] [Related]
62. Effects of riboflavin deficiency upon concentrations of riboflavin, flavin mononucleotide, and flavin adenine dinucleotide in Novikoff hepatoma in rats. Rivlin RS; Hornibrook R; Osnos M Cancer Res; 1973 Nov; 33(11):3019-23. PubMed ID: 4355989 [No Abstract] [Full Text] [Related]
63. Riboflavin metabolism in liver diseases. 3. Flavin contents of liver and other tissues of p-dimethyl-aminoazobenzene--fed rat and human liver. Sung JL; Yang WK Taiwan Yi Xue Hui Za Zhi; 1966 May; 65(5):242-8. PubMed ID: 4958970 [No Abstract] [Full Text] [Related]
64. Effect of hepatic disease on liver flavin and protein levels. Jusko WJ; Lewis GP Am J Clin Nutr; 1972 Mar; 25(3):265-8. PubMed ID: 5011906 [No Abstract] [Full Text] [Related]
65. Riboflavin metabolism in liver diseases. V. Clinical studies on the enzymatic splitting of flavin adenine dinucleotide in serum. Yang WK; Sung JL Taiwan Yi Xue Hui Za Zhi; 1966 Jun; 65(6):306-12. PubMed ID: 5224007 [No Abstract] [Full Text] [Related]
69. The biological fate of riboflavin in mammals. A survey of literature and own investigations. Christensen S Acta Pharmacol Toxicol (Copenh); 1973; 32():3-72. PubMed ID: 4586598 [No Abstract] [Full Text] [Related]